Recent FDA Drug Warnings Pharmacy Techs Should Know
Jun 24, 2016. The FDA added a new warning to the label of drugs containing the antipsychotic aripiprazole Abilify, Abilify Maintena. Risk factors for serious bleeding include age 60 years or older, history of stomach ulcers or bleeding, use of a. FDA Approves Continuous Glucose Monitoring System for Diabetes. ABILIFY is the first medication approved by the FDA as add-on treatment for MDD. ABILIFY should be used with caution in patients with a history of seizures or. Nov 20, 2007. The FDA has approved the antipsychotic drug Abilify for treatment of depression when used along with antidepressants.
US Food and Drug Administration Approves ABILIFY® aripiprazole
Aug 8, 2017. FDA Approves Abilify Maintena for Bipolar I Disorder Monotherapy. criteria for BP-I. "Eligible patients had a history of at least 1 previous manic. Apr 26, 2016. FDA Issues Complete Response Letter for Digital Medicine New Drug Application. ABILIFY aripiprazole is not approved for the treatment of patients with. Patients with history of a clinically significant low white blood cell. Mar 1, 2013. Administration FDA has approved ABILIFY MAINTENA™. history of illness and a history of relapse or symptom exacerbation when not.
FDA OKs Abilify for Depression - WebMD
Aug 2, 2017. Abilify Maintena OK'd by FDA for adults with bipolar I disorder. has approved a monthly injectable formulation of aripiprazole, Abilify Maintena. placebo in adults aged 18-65 years with bipolar I and a history of at least one. Jul 31, 2017. The FDA has approved extended-release injectable aripiprazole for. The patients had a history of at least one previous manic or mixed.
Otsuka, Proteus resubmit FDA application for novel drug-device.
May 23, 2017. One year after the FDA declined to approve Proteus Digital Health and Otsuka's new sensor-embedded formulation of Otsuka's antipsychotic drug Abilify. would be the first time in history that a medicine would be approved. Feb 22, 2017. Abilify was first approved by the FDA to treat schizophrenia in 2002. seizures, neuroleptic malignant syndrome NMS, or a history of suicidal.